\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ is\\ a\\ well\\-developed\\,\\ well\\-nourished\\ afebrile\\ boy\\.\\ his\\ tympanic\\ membranes\\ are\\ clear\\ and\\ non\\-bulging\\.\\ pupils\\ are\\ equal\\ and\\ reactive\\ to\\ light\\.\\ his\\ extraocular\\ muscles\\ are\\ intact\\ and\\ he\\ has\\ some\\ mild\\ tenderness\\ on\\ the\\ left\\ side\\ of\\ his\\ mandible\\.\\ his\\ oral\\ cavity\\ and\\ pharynx\\ appear\\ moist\\ without\\ gross\\ lesions\\ or\\ exudate\\.\\ pulmonary\\,\\ cardiac\\,\\ and\\ abdominal\\ exams\\ are\\ unremarkable\\.\\ he\\ does\\ not\\ have\\ any\\ rashes\\.\\ his\\ neurological\\ exam\\ is\\ significant\\ for\\ decreased\\ sensation\\ on\\ the\\ left\\ side\\ of\\ his\\ face\\ near\\ the\\ angle\\ of\\ the\\ mandible\\,\\ and\\ facial\\ asymetry\\ with\\ smiling\\.\\ otherwise\\,\\ his\\ neurological\\ exam\\ is\\ unremarkable\\.\ \(0\)\
\-\ initial\\ cbc\\ and\\ cmp\\ were\\ unremarkable\\.\ \(0\)\
\-\ surgical\\ resection\\ of\\ the\\ tumor\\ was\\ not\\ possible\\ due\\ to\\ it\\'s\\ anatomical\\ relationship\\ with\\ vital\\ structures\\.\\ patient\\ had\\ a\\ port\\ placed\\ and\\ underwent\\ radiation\\ and\\ chemotherapy\\ with\\ vincristine\\ and\\ cyclophosphamide\\.\\ the\\ tumor\\ responded\\ well\\ to\\ this\\ regimen\\,\\ and\\ is\\ now\\ quiescent\\.\\ however\\,\\ he\\ did\\ have\\ recurrent\\ sinusitis\\ after\\ treatment\\ and\\ eventually\\ received\\ a\\ bilateral\\ endoscopic\\ sinus\\ procedure\\ with\\ maxillary\\ antrostomy\\.\ \(0\)\
\-\ head\\ ct\\ without\\ contrast\\:\ \(0\)\
\-\ \\â\\€\\¢extensive\\ bony\\ destruction\\ at\\ the\\ skull\\ base\\ involving\\ the\\ left\\ sphenoid\\ bone\\,\\ clivus\\,\\ dorsum\\ sellae\\,\\ tip\\ of\\ the\\ left\\ petrous\\ apex\\,\\ left\\ optic\\ apex\ \(0\)\
\-\ \\â\\€\\¢soft\\ tissue\\ density\\ extending\\ from\\ the\\ sphenoid\\ sinus\\ into\\ the\\ medial\\ aspect\\ of\\ the\\ left\\ middle\\ fossa\ \(0\)\
\-\ brain\\ mri\\,\\ w\\/wo\\ contrast\ \(0\)\
\-\ \\â\\€\\¢infiltrative\\ enhancing\\ nasopharyngeal\\ midline\\ mass\\ that\\ extends\\ into\\ the\\ medial\\ aspect\\ of\\ the\\ left\\ middle\\ cranial\\ fossa\\,\\ sphenoid\\ sinus\\ and\\ anteriorly\\ into\\ the\\ ethmoid\\ air\\ cells\ \(0\)\
\-\ \\â\\€\\¢there\\ is\\ a\\ large\\ central\\ non\\-enhancing\\ portion\\ of\\ the\\ mass\\ suggesting\\ central\\ necrosis\ \(0\)\
\-\ nasopharyngeal\\ embryonal\\ rhabdomyosarcoma\ \(1\)\
\-\ 1\\.\\ rhabdomyosarcoma\\ \ \(0\)\
\-\ 2\\.\\ chondrosarcoma\\ \ \(0\)\
\-\ 3\\.\\ nasopharyngeal\\ sarcoma\\ \ \(0\)\
\-\ 4\\.\\ nasopharyngeal\\ carcinoma\\ \ \(0\)\
\-\ 5\\.\\ craniopharyngioma\ \(0\)\
\-\ previously\\ healthy\\ 6\\ year\\-old\\ male\\ presents\\ with\\ a\\ 3\\ week\\ history\\ of\\ headaches\\.\\ approximately\\ 1\\ week\\ prior\\,\\ he\\ was\\ admitted\\ for\\ observation\\.\\ the\\ ct\\ scan\\ of\\ his\\ head\\ from\\ the\\ outside\\ institution\\ was\\ interpreted\\ as\\ sinusitis\\ and\\ he\\ was\\ discharged\\ on\\ augmentin\\.\\ \\ \\ headaches\\ have\\ persisted\\ since\\ time\\ of\\ discharge\\ and\\ they\\ are\\ now\\ accompanied\\ with\\ emesis\\,\\ drooling\\,\\ left\\-sided\\ facial\\ droop\\,\\ decreased\\ oral\\ intake\\,\\ and\\ blurred\\ vision\\.\ \(0\)\
\-\ this\\ patient\\ was\\ found\\ to\\ have\\ nasopharyngeal\\ embryonal\\ rhabdomyosarcoma\\.\\ the\\ primary\\ site\\,\\ histological\\ subtype\\,\\ and\\ age\\ of\\ diagnosis\\ is\\ consistent\\ with\\ what\\ has\\ been\\ described\\ in\\ the\\ literature\\.\\ he\\ did\\ not\\ have\\ nodal\\ involvement\\,\\ meningeal\\ invasion\\,\\ or\\ distant\\ metastases\\ at\\ diagnosis\\.\\ the\\ anatomical\\ location\\ of\\ his\\ tumor\\ made\\ him\\ a\\ poor\\ surgical\\ candidate\\.\ \(0\)\
\-\ this\\ patient\\ would\\ be\\ considered\\ in\\ clinical\\ group\\ iii\\ with\\ a\\ tnm\\ staging\\ of\\ 2\\ in\\ an\\ unfavorable\\ location\\.\\ based\\ on\\ these\\ parameters\\,\\ his\\ prognosis\\ for\\ event\\-free\\ three\\ year\\ survival\\ is\\ roughly\\ 70\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.06343840113565667\ \(0\)\
\-\ his\\:\\ 0\\.05273852307595143\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.03088769960642844\ \(0\)\
\-\ he\\:\\ 0\\.030631957285220807\ \(0\)\
\-\ sphenoid\\:\\ 0\\.030546522998415926\ \(0\)\
\-\ embryonal\\:\\ 0\\.024715186236587045\ \(0\)\
\-\ anatomical\\:\\ 0\\.02304724290998438\ \(0\)\
\-\ mandible\\:\\ 0\\.021645902819156043\ \(0\)\
\-\ sinusitis\\:\\ 0\\.02117480690817391\ \(0\)\
\-\ sinus\\:\\ 0\\.020075967685069192\ \(0\)\
\-\ have\\:\\ 0\\.019811970860439954\ \(0\)\
\-\ antrostomy\\:\\ 0\\.018876913113418627\ \(0\)\
\-\ \\â\\€\\¢extensive\\:\\ 0\\.018876913113418627\ \(0\)\
\-\ sellae\\:\\ 0\\.018876913113418627\ \(0\)\
\-\ \\â\\€\\¢infiltrative\\:\\ 0\\.018876913113418627\ \(0\)\
\-\ \\â\\€\\¢there\\:\\ 0\\.018876913113418627\ \(0\)\
\-\ event\\-free\\:\\ 0\\.018876913113418627\ \(0\)\
\-\ apex\\:\\ 0\\.018829455315502786\ \(0\)\
\-\ unremarkable\\:\\ 0\\.018173874209949\ \(0\)\
\-\ non\\-bulging\\:\\ 0\\.017392657908793477\ \(0\)\
\-\ asymetry\\:\\ 0\\.017392657908793477\ \(0\)\
\-\ w\\/wo\\:\\ 0\\.017392657908793477\ \(0\)\
\-\ smiling\\:\\ 0\\.016524424272587556\ \(0\)\
\-\ quiescent\\:\\ 0\\.016524424272587556\ \(0\)\
\-\ \\â\\€\\¢soft\\:\\ 0\\.016524424272587556\ \(0\)\
\-\ tnm\\:\\ 0\\.016524424272587556\ \(0\)\
\-\ facial\\:\\ 0\\.01591285651452805\ \(0\)\
\-\ neurological\\:\\ 0\\.0158352231758019\ \(0\)\
\-\ oral\\:\\ 0\\.015420054245642453\ \(0\)\
\-\ unfavorable\\:\\ 0\\.015040169067962406\ \(0\)\
\-\ fossa\\:\\ 0\\.014915630110069076\ \(0\)\
\-\ augmentin\\:\\ 0\\.014710081959124594\ \(0\)\
\-\ left\\:\\ 0\\.014331342365975167\ \(0\)\
\-\ headaches\\:\\ 0\\.013989046420005475\ \(0\)\
\-\ exudate\\:\\ 0\\.013946324049191548\ \(0\)\
\-\ drooling\\:\\ 0\\.013555913863337255\ \(0\)\
\-\ parameters\\:\\ 0\\.013555913863337255\ \(0\)\
\-\ well\\-nourished\\:\\ 0\\.013384516202366085\ \(0\)\
\-\ responded\\:\\ 0\\.013384516202366085\ \(0\)\
\-\ middle\\:\\ 0\\.013383978456712796\ \(0\)\
\-\ \\,\\:\\ 0\\.01333261564646169\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.013225826754499443\ \(0\)\
\-\ did\\:\\ 0\\.01321378432973415\ \(0\)\
\-\ into\\:\\ 0\\.01306205375562981\ \(0\)\
\-\ well\\-developed\\:\\ 0\\.012939892294918024\ \(0\)\
\-\ tumor\\:\\ 0\\.012798066177371378\ \(0\)\
\-\ location\\:\\ 0\\.012765343412864638\ \(0\)\
\-\ roughly\\:\\ 0\\.012687680227131336\ \(0\)\
\-\ side\\:\\ 0\\.012678571742030282\ \(0\)\
\-\ pharynx\\:\\ 0\\.012571904592719611\ \(0\)\
\-\ rashes\\:\\ 0\\.012571904592719611\ \(0\)\
\-\ droop\\:\\ 0\\.012571904592719611\ \(0\)\
\-\ now\\:\\ 0\\.012510131005146242\ \(0\)\
\-\ are\\:\\ 0\\.012471883003528925\ \(0\)\
\-\ week\\:\\ 0\\.012428331556009543\ \(0\)\
\-\ port\\:\\ 0\\.012357593118293523\ \(0\)\
\-\ vincristine\\:\\ 0\\.012357593118293523\ \(0\)\
\-\ clivus\\:\\ 0\\.012357593118293523\ \(0\)\
\-\ subtype\\:\\ 0\\.012357593118293523\ \(0\)\
\-\ dorsum\\:\\ 0\\.012257978523786258\ \(0\)\
\-\ persisted\\:\\ 0\\.012257978523786258\ \(0\)\
\-\ blurred\\:\\ 0\\.012257978523786258\ \(0\)\
\-\ nodal\\:\\ 0\\.012257978523786258\ \(0\)\
\-\ central\\:\\ 0\\.012041247780984836\ \(0\)\
\-\ tympanic\\:\\ 0\\.011819446590925417\ \(0\)\
\-\ cmp\\:\\ 0\\.011819446590925417\ \(0\)\
\-\ petrous\\:\\ 0\\.011741571549874291\ \(0\)\
\-\ medial\\:\\ 0\\.011705779501456326\ \(0\)\
\-\ meningeal\\:\\ 0\\.011666429537430459\ \(0\)\
\-\ moist\\:\\ 0\\.011593835208360477\ \(0\)\
\-\ interpreted\\:\\ 0\\.01152362145499219\ \(0\)\
\-\ aspect\\:\\ 0\\.011495896935688896\ \(0\)\
\-\ regimen\\:\\ 0\\.011455637090292873\ \(0\)\
\-\ histological\\:\\ 0\\.011389744887580338\ \(0\)\
\-\ accompanied\\:\\ 0\\.011263748099522665\ \(0\)\
\-\ intake\\:\\ 0\\.011263748099522665\ \(0\)\
\-\ candidate\\:\\ 0\\.011263748099522665\ \(0\)\
\-\ extraocular\\:\\ 0\\.011203425022506186\ \(0\)\
\-\ non\\-enhancing\\:\\ 0\\.01114475484223185\ \(0\)\
\-\ decreased\\:\\ 0\\.010881183737578414\ \(0\)\
\-\ relationship\\:\\ 0\\.010873337913668372\ \(0\)\
\-\ endoscopic\\:\\ 0\\.010773723319161108\ \(0\)\
\-\ membranes\\:\\ 0\\.01072560157215456\ \(0\)\
\-\ ethmoid\\:\\ 0\\.010678537532071528\ \(0\)\
\-\ distant\\:\\ 0\\.010678537532071528\ \(0\)\
\-\ was\\:\\ 0\\.010581129788155104\ \(0\)\
\-\ staging\\:\\ 0\\.01054325080483056\ \(0\)\
\-\ head\\:\\ 0\\.01037944886755416\ \(0\)\
\-\ exams\\:\\ 0\\.010335191386300265\ \(0\)\
\-\ emesis\\:\\ 0\\.010335191386300265\ \(0\)\
\-\ eventually\\:\\ 0\\.010074185352876203\ \(0\)\
\-\ him\\:\\ 0\\.010039366250367039\ \(0\)\
\-\ pupils\\:\\ 0\\.010005104277462455\ \(0\)\
\-\ maxillary\\:\\ 0\\.010005104277462455\ \(0\)\
\-\ institution\\:\\ 0\\.009971381885667723\ \(0\)\
\-\ literature\\:\\ 0\\.009841564708330603\ \(0\)\
\-\ survival\\:\\ 0\\.009810303895865609\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.009689633796184385\ \(0\)\
\-\ what\\:\\ 0\\.0096604996376067\ \(0\)\
\-\ equal\\:\\ 0\\.009575402574117375\ \(0\)\
\-\ group\\:\\ 0\\.009520493729120935\ \(0\)\
\-\ tip\\:\\ 0\\.009389082709043222\ \(0\)\
\-\ observation\\:\\ 0\\.009389082709043222\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.009148230496138105\ \(0\)\
\-\ destruction\\:\\ 0\\.00903725604674927\ \(0\)\
\-\ left\\-sided\\:\\ 0\\.009015734984964469\ \(0\)\
\-\ face\\:\\ 0\\.008973331072124682\ \(0\)\
\-\ anteriorly\\:\\ 0\\.008973331072124682\ \(0\)\
\-\ suggesting\\:\\ 0\\.00889096216242919\ \(0\)\
\-\ discharge\\:\\ 0\\.008870855652044094\ \(0\)\
\-\ invasion\\:\\ 0\\.00881164466418433\ \(0\)\
\-\ 70\\:\\ 0\\.00879226600140078\ \(0\)\
\-\ vital\\:\\ 0\\.008754026991978924\ \(0\)\
\-\ gross\\:\\ 0\\.00871645887709475\ \(0\)\
\-\ prognosis\\:\\ 0\\.008679538520703944\ \(0\)\
\-\ reactive\\:\\ 0\\.008661314345826196\ \(0\)\
\-\ without\\:\\ 0\\.008616758742433235\ \(0\)\
\-\ angle\\:\\ 0\\.008589930148251053\ \(0\)\
\-\ iii\\:\\ 0\\.008589930148251053\ \(0\)\
\-\ light\\:\\ 0\\.008537911534612842\ \(0\)\
\-\ received\\:\\ 0\\.008503921493592949\ \(0\)\
\-\ optic\\:\\ 0\\.00847046256874695\ \(0\)\
\-\ afebrile\\:\\ 0\\.008453927138139005\ \(0\)\
\-\ vision\\:\\ 0\\.008453927138139005\ \(0\)\
\-\ is\\:\\ 0\\.008428341431890963\ \(0\)\
\-\ sensation\\:\\ 0\\.008405073438425578\ \(0\)\
\-\ diagnosis\\:\\ 0\\.008403508911265182\ \(0\)\
\-\ discharged\\:\\ 0\\.00838903345613616\ \(0\)\
\-\ muscles\\:\\ 0\\.008357309503705453\ \(0\)\
\-\ healthy\\:\\ 0\\.008249836817358868\ \(0\)\
\-\ poor\\:\\ 0\\.008234914613255885\ \(0\)\
\-\ contrast\\:\\ 0\\.008191758830012443\ \(0\)\
\-\ cbc\\:\\ 0\\.008176244432981549\ \(0\)\
\-\ sarcoma\\:\\ 0\\.00814750134875855\ \(0\)\
\-\ exam\\:\\ 0\\.008039545781368472\ \(0\)\
\-\ cavity\\:\\ 0\\.008009303230690946\ \(0\)\
\-\ cranial\\:\\ 0\\.007956428257264026\ \(0\)\
\-\ not\\:\\ 0\\.007932453994059542\ \(0\)\
\-\ extends\\:\\ 0\\.007930472453126242\ \(0\)\
\-\ near\\:\\ 0\\.00791761158790095\ \(0\)\
\-\ admitted\\:\\ 0\\.007904827504418071\ \(0\)\
\-\ 5\\.\\:\\ 0\\.007892119291313544\ \(0\)\
\-\ metastases\\:\\ 0\\.007817414239920738\ \(0\)\
\-\ skull\\:\\ 0\\.007793080709620277\ \(0\)\
\-\ described\\:\\ 0\\.007793080709620277\ \(0\)\
\-\ site\\:\\ 0\\.007733429843446902\ \(0\)\
\-\ recurrent\\:\\ 0\\.007721696512045134\ \(0\)\
\-\ surgical\\:\\ 0\\.007692598587800658\ \(0\)\
\-\ previously\\:\\ 0\\.0076868774095359685\ \(0\)\
\-\ outside\\:\\ 0\\.007675395732573686\ \(0\)\
\-\ procedure\\:\\ 0\\.0076639752915129535\ \(0\)\
\-\ appear\\:\\ 0\\.0074890758674995336\ \(0\)\
\-\ placed\\:\\ 0\\.007406706957804038\ \(0\)\
\-\ considered\\:\\ 0\\.007386600447418944\ \(0\)\
\-\ cells\\:\\ 0\\.007337144955353314\ \(0\)\
\-\ patient\\:\\ 0\\.007336975853673559\ \(0\)\
\-\ bony\\:\\ 0\\.007317678206528363\ \(0\)\
\-\ made\\:\\ 0\\.007288805935998841\ \(0\)\
\-\ necrosis\\:\\ 0\\.007222913733286306\ \(0\)\
\-\ 4\\.\\:\\ 0\\.007204453898074514\ \(0\)\
\-\ base\\:\\ 0\\.007168004888289865\ \(0\)\
\-\ midline\\:\\ 0\\.007079507681667069\ \(0\)\
\-\ structures\\:\\ 0\\.007045108104571123\ \(0\)\
\-\ based\\:\\ 0\\.006977923687937817\ \(0\)\
\-\ cardiac\\:\\ 0\\.006969671933513855\ \(0\)\
\-\ has\\:\\ 0\\.006872376747298835\ \(0\)\
\-\ clear\\:\\ 0\\.006765581612733717\ \(0\)\
\-\ intact\\:\\ 0\\.006721123386934083\ \(0\)\
\-\ year\\-old\\:\\ 0\\.006721123386934083\ \(0\)\
\-\ since\\:\\ 0\\.006721123386934083\ \(0\)\
\-\ involvement\\:\\ 0\\.0067065067593743396\ \(0\)\
\-\ portion\\:\\ 0\\.006627851493274275\ \(0\)\
\-\ they\\:\\ 0\\.00659303239076511\ \(0\)\
\-\ otherwise\\:\\ 0\\.006572409493418298\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.006558770417860526\ \(0\)\
\-\ and\\:\\ 0\\.006552790358560414\ \(0\)\
\-\ would\\:\\ 0\\.006511706377777495\ \(0\)\
\-\ involving\\:\\ 0\\.006420572299792921\ \(0\)\
\-\ underwent\\:\\ 0\\.0062787923671910485\ \(0\)\
\-\ 3\\.\\:\\ 0\\.006260972617003699\ \(0\)\
\-\ does\\:\\ 0\\.006243299936582456\ \(0\)\
\-\ boy\\:\\ 0\\.006219960984852187\ \(0\)\
\-\ the\\:\\ 0\\.006216777256479961\ \(0\)\
\-\ on\\:\\ 0\\.006200351283643924\ \(0\)\
\-\ air\\:\\ 0\\.006191140527948536\ \(0\)\
\-\ this\\:\\ 0\\.006174328993452675\ \(0\)\
\-\ three\\:\\ 0\\.006168360232006232\ \(0\)\
\-\ possible\\:\\ 0\\.006162702824162896\ \(0\)\
\-\ extending\\:\\ 0\\.0061514326527618785\ \(0\)\
\-\ initial\\:\\ 0\\.006063345060555263\ \(0\)\
\-\ density\\:\\ 0\\.006020623890492418\ \(0\)\
\-\ radiation\\:\\ 0\\.006004820662874382\ \(0\)\
\-\ a\\:\\ 0\\.005944750776724217\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0058189382051397395\ \(0\)\
\-\ found\\:\\ 0\\.005766650138013089\ \(0\)\
\-\ any\\:\\ 0\\.005761959385593777\ \(0\)\
\-\ enhancing\\:\\ 0\\.005738658528661155\ \(0\)\
\-\ 1\\.\\:\\ 0\\.005715608493142615\ \(0\)\
\-\ resection\\:\\ 0\\.005706457506467278\ \(0\)\
\-\ approximately\\:\\ 0\\.005661280142517308\ \(0\)\
\-\ clinical\\:\\ 0\\.005630213704638125\ \(0\)\
\-\ age\\:\\ 0\\.0055694011253625405\ \(0\)\
\-\ tenderness\\:\\ 0\\.005565122747069879\ \(0\)\
\-\ some\\:\\ 0\\.005556591550035887\ \(0\)\
\-\ brain\\:\\ 0\\.005506106045616193\ \(0\)\
\-\ 6\\:\\ 0\\.0054649253990896665\ \(0\)\
\-\ from\\:\\ 0\\.005423707550981638\ \(0\)\
\-\ primary\\:\\ 0\\.00542052304688586\ \(0\)\
\-\ pulmonary\\:\\ 0\\.005345932141798852\ \(0\)\
\-\ carcinoma\\:\\ 0\\.005186140621018987\ \(0\)\
\-\ time\\:\\ 0\\.00516831097909917\ \(0\)\
\-\ scan\\:\\ 0\\.005122636960241924\ \(0\)\
\-\ ct\\:\\ 0\\.005119073462064424\ \(0\)\
\-\ however\\:\\ 0\\.005095006543034413\ \(0\)\
\-\ mass\\:\\ 0\\.005089768766370726\ \(0\)\
\-\ been\\:\\ 0\\.004978147514912187\ \(0\)\
\-\ at\\:\\ 0\\.004958300440392433\ \(0\)\
\-\ significant\\:\\ 0\\.004920443578274568\ \(0\)\
\-\ lesions\\:\\ 0\\.004898416501807169\ \(0\)\
\-\ due\\:\\ 0\\.004882820456001798\ \(0\)\
\-\ mild\\:\\ 0\\.0048185298799381954\ \(0\)\
\-\ these\\:\\ 0\\.004761980068432206\ \(0\)\
\-\ prior\\:\\ 0\\.004698314287371228\ \(0\)\
\-\ for\\:\\ 0\\.004683778256805451\ \(0\)\
\-\ abdominal\\:\\ 0\\.0045737028653578485\ \(0\)\
\-\ bone\\:\\ 0\\.004546969339314497\ \(0\)\
\-\ consistent\\:\\ 0\\.004486720061737052\ \(0\)\
\-\ bilateral\\:\\ 0\\.004440723189110159\ \(0\)\
\-\ 1\\:\\ 0\\.00435401791854327\ \(0\)\
\-\ tissue\\:\\ 0\\.004337090339298916\ \(0\)\
\-\ or\\:\\ 0\\.004289176655090825\ \(0\)\
\-\ 3\\:\\ 0\\.004284744168536488\ \(0\)\
\-\ \\%\\:\\ 0\\.004268353390462543\ \(0\)\
\-\ mri\\:\\ 0\\.004204016819945653\ \(0\)\
\-\ were\\:\\ 0\\.00415478872952874\ \(0\)\
\-\ well\\:\\ 0\\.004139359642331158\ \(0\)\
\-\ it\\:\\ 0\\.004113165705638151\ \(0\)\
\-\ \\'s\\:\\ 0\\.00403436106716712\ \(0\)\
\-\ large\\:\\ 0\\.004001161524263554\ \(0\)\
\-\ had\\:\\ 0\\.003948286550836635\ \(0\)\
\-\ 2\\:\\ 0\\.003940266587817016\ \(0\)\
\-\ after\\:\\ 0\\.0037858698128676715\ \(0\)\
\-\ presents\\:\\ 0\\.0037379963501240386\ \(0\)\
\-\ treatment\\:\\ 0\\.0037036765730211717\ \(0\)\
\-\ to\\:\\ 0\\.0036579709502611245\ \(0\)\
\-\ of\\:\\ 0\\.0034926192958711737\ \(0\)\
\-\ male\\:\\ 0\\.0033087913016862382\ \(0\)\
\-\ that\\:\\ 0\\.0031605583052651464\ \(0\)\
\-\ be\\:\\ 0\\.002821748872256808\ \(0\)\
\-\ as\\:\\ 0\\.0027678319184028435\ \(0\)\
\-\ in\\:\\ 0\\.002707048587624764\ \(0\)\
\-\ an\\:\\ 0\\.002530331615170728\ \(0\)\
\-\ history\\:\\ 0\\.002527225990807459\ \(0\)\
\-\ \\:\\:\\ 0\\.0024202886852048504\ \(0\)\
\-\ year\\:\\ 0\\.0020473346237107385\ \(0\)\
\-\ with\\:\\ 0\\.0020043541942593533\ \(0\)\
\-\ \\.\\:\\ 0\\.0018243872940820354\ \(0\)\
